SRF Receives Additional $1M Donation from Pineapple Fund

SENS RESEARCH FOUNDATION RECEIVES AN ADDITIONAL $1 MILLION BITCOIN DONATION FROM PINEAPPLE FUND

MOUNTAIN VIEW, Calif.— February 2, 2018SENS Research Foundation (SRF), a leading nonprofit focused on the development of rejuvenation biotechnologies to address the diseases of aging, announced today the receipt of an additional $1 million bitcoin donation from the Pineapple Fund and a second anonymous $1 million donation. The Pineapple Fund announced in December its commitment to donating $86 million in bitcoin to charities and causes around the world, with SENS Research Foundation receiving $1 million dollars in December.

"SENS Research Foundation is tremendously honored to be receiving a second million dollar Pineapple Fund donation," said Mike Kope, CEO, SENS Research Foundation. "As a nonprofit, our work is solely dependent on the generosity of our donors. The Pineapple Fund's support will support the growth of our organization as we continue to fight the diseases of aging."

"When I was a little kid, I was going on a trip with my grandmother. I had hoped that before she passes away, it would be possible to take a pill to live longer. Regenerative medicine for ageing will be transformative to medicine and humanity, and I'm excited to be supporting SENS Research Foundation!," said the founder of the Pineapple Fund.

To learn more and to donate to the SENS Research Foundation please go to www.sens.org. To learn more about the Pineapple Fund go to www.pineapplefund.org.

 

About SENS Research Foundation (SRF)

SENS Research Foundation is a 501(c)(3) nonprofit that works to research, develop, and promote comprehensive regenerative medicine solutions for the diseases of aging. SRF is focused on a damage repair paradigm for treating the diseases of aging, which it advances through scientific research, advocacy, and education. SENS Research Foundation supports research projects at universities and institutes around the world with the goal of curing such age-related diseases as macular degeneration, heart disease, cancer, and Alzheimer's disease. Educating the public and training researchers to support a growing regenerative medicine field are also major endeavors of the organization that are being accomplished though advocacy campaigns and educational programs. For more information, visit www.sens.org.

 

Media Contact:

Jerri Barrett
408-204-7229
jerri.barrett@sens.org